BioPlus Acquisition Corp.

Epiphany Technology Acquisitions Corp | SEC Filings

SEC Filings

Epiphany Technology Acquisitions Corp | IPO Icon

IPO Prospectus

"We are focused on the life sciences industry across the US, EU, Israel and Australasia(1), where we have deep clinical, regulatory, operational and commercial expertise. Furthermore, we believe our management team and board’s extensive experience positions us to be therapeutic area agnostic. We plan to identify and assess target assets leading to an efficient pathway to a merger."

Ross Haghighat, CEO & CFO

(1) Excluding China, Hong Kong and Macau

“SPACs with operators at the helm outperformed others”

“Operator-led SPACs are more focused and better governed”

Recent News and Announcements